SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905148-13-000722
Filing Date
2013-07-16
Accepted
2013-07-16 11:19:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc13-440_fmsc13d.htm SC 13D 150449
  Complete submission text file 0000905148-13-000722.txt   152117
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-12338 | Film No.: 13969704
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 157 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

IRS No.: 134015739 | State of Incorp.: DE
Type: SC 13D